Abstract:L-Tryptophan is an essential amino acid and a precursor of several physiologically active metabolites. In the placenta, the serotonin and kynurenine metabolic pathways of tryptophan metabolism have been identified, giving rise to various molecules of neuroactive or immunoprotective properties, such as serotonin, melatonin, kynurenine, kynurenic acid, or quinolinic acid. Current literature suggests that optimal levels of these molecules in the fetoplacental unit are crucial for proper placenta functions, fetal development and programming. Placenta is a unique endocrine organ that, being equipped with a battery of biotransformation enzymes and transporters, precisely orchestrates homeostasis of tryptophan metabolic pathways. However, because pregnancy is a dynamic process and placental/fetal needs are continuously changing throughout gestation, placenta must adapt to these changes and ensure proper communication in the feto-placental unit. Therefore, in this study we investigated alterations of placental tryptophan metabolic pathways throughout gestation. Quantitative polymerase chain reaction (PCR) analysis of 21 selected genes was carried out in first trimester (n = 13) and term (n = 32) placentas. Heatmap analysis with hierarchical clustering revealed differential gene expression of serotonin and kynurenine pathways across gestation. Subsequently, digital droplet PCR, Western blot, and functional analyses of the rate-limiting enzymes suggest preferential serotonin synthesis early in pregnancy with a switch to kynurenine production toward term. Correspondingly, increased function and/or protein expression of serotonin degrading enzyme and transporters at term indicates efficient placental uptake and metabolic degradation of serotonin. Lastly, gene expression analysis in choriocarcinoma-derived cell lines (BeWo, BeWo b30, JEG-3) revealed dissimilar expression patterns and divergent effect of syncytialization compared to primary trophoblast cells isolated from human term placentas; these findings show that the commonly used in vitro placental models are not suitable to study placental handling of tryptophan. Altogether, our data provide the first comprehensive evidence of changes in placental homeostasis of tryptophan and its metabolites as a function of gestational age, which is critical for proper placental function and fetal development.

Serotonin homeostasis in the materno‐foetal interface at term: Role of transporters (SERT/SLC6A4 and OCT3/SLC22A3) and monoamine oxidase A (MAO‐A) in uptake and degradation of serotonin by human and rat term placenta

Characterization of a human placental clearance system to regulate serotonin levels in the fetoplacental unit

Pathway of Maternal Serotonin to the Human Embryo and Fetus

Dynamics of Tryptophan Metabolic Pathways in Human Placenta and Placental-Derived Cells: Effect of Gestation Age and Trophoblast Differentiation

Serotonin transporter-dependent histone serotonylation in placenta contributes to the neurodevelopmental transcriptome

Serotonin transporter protects the placental cells against apoptosis in caspase 3-independent pathway

Metformin inhibits OCT3-mediated serotonin transport in the placenta

Developmental expression of catecholamine system in the human placenta and rat fetoplacental unit

Studies on the localization of 5-hydroxytryptamine and its receptors in human placenta

Beyond the Brain: Perinatal Exposure of Rats to Serotonin Enhancers Induces Long-Term Changes in the Jejunum and Liver

Sex-Specific Transcriptomic Changes in the Villous Tissue of Placentas of Pregnant Women Using a Selective Serotonin Reuptake Inhibitor

Pathological shifts in tryptophan metabolism in human term placenta exposed to LPS or poly I:C†

Perinatal treatment

Maternal depression and anxiety are associated with altered gene expression in the human placenta without modification by antidepressant use: implications for fetal programming

Inflammation-Induced Modulation of Placental Serotonin Can Be Prevented by Immunoglobulin Administration

Association with Altered Placental Serotonin Transporter Structure and/or Expression

Maternal Prepregnancy 5-Hydroxytryptamine Exposure Affects the Early Development of the Fetus

New Insights into How Serotonin Selective Reuptake Inhibitors Shape the Developing Brain

Regulation of drug transporter expression and function in the placenta

Effects of selective serotonin-reuptake inhibitors (SSRIs) on human villous trophoblasts syncytialization

Association of MAOA, 5-HTT, and NET Promoter Polymorphisms with Gene Expression and Protein Activity in Human Placentas.